KLRK1 and cancer: Moreover, upregulating NKG2D ligands through the use of stress inducers such as histone deacetylase inhibitors (HDACi), heat shock, or short-chain fatty acids (SCFAs) may help treat cancers that evade immune recognition and clearance by blocking surface expression of NKG2D Ligands [19].